Fogli S - Search Results

1

Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer.

Crucitta S, Ruglioni M, Novi C, Manganiello M, Arici R, Petrini I, Pardini E, Cucchiara F, Marmorino F, Cremolini C, Fogli S, Danesi R, Del Re M. Crucitta S, et al. Among authors: fogli s. Clin Chim Acta. 2023 Feb 15;541:117239. doi: 10.1016/j.cca.2023.117239. Epub 2023 Feb 2. Clin Chim Acta. 2023. PMID: 36736684 Free article.

2

New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration.

Rassu G, Gavini E, Jonassen H, Zambito Y, Fogli S, Breschi MC, Giunchedi P. Rassu G, et al. Among authors: fogli s. J Pharm Sci. 2009 Dec;98(12):4852-65. doi: 10.1002/jps.21751. J Pharm Sci. 2009. PMID: 19479981

3

Selection of a human butyrylcholinesterase-like antibody single-chain variable fragment resistant to AChE inhibitors from a phage library expressed in E. coli.

Podestà A, Rossi S, Massarelli I, Carpi S, Adinolfi B, Fogli S, Bianucci AM, Nieri P. Podestà A, et al. Among authors: fogli s. MAbs. 2014 Jul-Aug;6(4):1084-93. doi: 10.4161/mabs.28635. MAbs. 2014. PMID: 24675419 Free PMC article.

4

Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles.

Ziedan NI, Stefanelli F, Fogli S, Westwell AD. Ziedan NI, et al. Among authors: fogli s. Eur J Med Chem. 2010 Oct;45(10):4523-30. doi: 10.1016/j.ejmech.2010.07.012. Epub 2010 Jul 21. Eur J Med Chem. 2010. PMID: 20705365

5

Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents.

Md Tohid SF, Ziedan NI, Stefanelli F, Fogli S, Westwell AD. Md Tohid SF, et al. Among authors: fogli s. Eur J Med Chem. 2012 Oct;56:263-70. doi: 10.1016/j.ejmech.2012.08.009. Epub 2012 Aug 14. Eur J Med Chem. 2012. PMID: 22955095

6

Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo.

Bocci G, Danesi R, Benelli U, Innocenti F, Di Paolo A, Fogli S, Del Tacca M. Bocci G, et al. Among authors: fogli s. Cancer Chemother Pharmacol. 1999;43(3):205-12. doi: 10.1007/s002800050885. Cancer Chemother Pharmacol. 1999. PMID: 9923550

7

Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens.

Innocenti F, Danesi R, Bocci G, Fogli S, Di Paolo A, Del Tacca M. Innocenti F, et al. Among authors: fogli s. Cancer Chemother Pharmacol. 1999;43(2):133-40. doi: 10.1007/s002800050873. Cancer Chemother Pharmacol. 1999. PMID: 9923818

8

An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma.

Fogli S, Danesi R, Innocenti F, Di Paolo A, Bocci G, Barbara C, Del Tacca M. Fogli S, et al. Ther Drug Monit. 1999 Jun;21(3):367-75. doi: 10.1097/00007691-199906000-00022. Ther Drug Monit. 1999. PMID: 10365655 Clinical Trial.

9

Manumycin inhibits ras signal transduction pathway and induces apoptosis in COLO320-DM human colon tumour cells.

Di Paolo A, Danesi R, Nardini D, Bocci G, Innocenti F, Fogli S, Barachini S, Marchetti A, Bevilacqua G, Del Tacca M. Di Paolo A, et al. Among authors: fogli s. Br J Cancer. 2000 Feb;82(4):905-12. doi: 10.1054/bjoc.1999.1018. Br J Cancer. 2000. PMID: 10732765 Free PMC article.

10

Pharmacogenetic determinants of anti-cancer drug activity and toxicity.

Danesi R, De Braud F, Fogli S, Di Paolo A, Del Tacca M. Danesi R, et al. Among authors: fogli s. Trends Pharmacol Sci. 2001 Aug;22(8):420-6. doi: 10.1016/s0165-6147(00)01742-9. Trends Pharmacol Sci. 2001. PMID: 11479005 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters